Dosing-time dependent effect of dexamethasone on bone density in rats
スポンサーリンク
概要
- 論文の詳細を見る
AimsWhile glucocorticoids are widely used to treat patients with various diseases, they often cause adverse effects such as bone fractures. In this study, we investigated whether the decrease in bone density induced by glucocorticoid therapy was ameliorated by optimizing a dosing-time.Main methodsRats were administered with dexamethasone (Dex) orally (1 mg/kg/day) for 6 weeks at a resting or an active period. After the end of the treatment, bone density of femur, biomarkers of bone formation and resorption, and other biomedical variables were measured.Key findingsBone density of femur was significantly decreased by the 6-week treatment with Dex, and the degree of decrease in the 14 HALO (hours after light on) dosing group (an active period) was larger than that in the 2 HALO dosing group (a resting period). Although urinary calcium excretion was accelerated by Dex treatment, secondary hyperparathyroidism was not detected. Histomorphometry analysis showed that Dex suppressed bone resorption, which was larger in the 2 HALO than in the 14 HALO groups. These data indicate that Dex equally suppressed bone formation in the 2 and 14 HALO groups, but inhibited bone resorption more in the 2 HALO than in the 14 HALO groups.SignificanceThis study shows that the decrease in bone density induced by Dex was changed by its dosing-time.
論文 | ランダム
- 八丈島,西山火山南東麓における最近2,500年間の噴出物の層序と噴火年代
- 八丈島,東山火山のテフロクロノロジー
- A-3 培養鶏胚表皮分化の電顕的研究-ハイドロコーチゾンによる角質化(第 10 回 杏林医学会総会)
- 機能性高分子-7-金属を含んだ高分子触媒
- 国際的視野にたった分析法の信頼性確保--AOACの考え方と役割 (特集 国際化に対応した食品安全性の確保と管理基準)